Molbank (Jan 2020)

1-Phenyl-8-[[4-(pyrrolo[1,2-<i>a</i>]quinoxalin-4-yl)phenyl]methyl]-1,3,8-triazaspiro[4.5]decan-4-one: Synthesis, Crystal Structure and Anti-Leukemic Activity

  • Jean Guillon,
  • Solène Savrimoutou,
  • Sandra Rubio,
  • Stéphane Moreau,
  • Noël Pinaud,
  • Mathieu Marchivie,
  • Vanessa Desplat

DOI
https://doi.org/10.3390/M1113
Journal volume & issue
Vol. 2020, no. 1
p. M1113

Abstract

Read online

1-Phenyl-8-[[4-(pyrrolo[1,2-a]quinoxalin-4-yl)phenyl]methyl]-1,3,8-triazaspiro[4.5]decan-4-one has been successfully synthesized via a multi-step pathway starting from 2-nitroaniline. Structure characterization of this original pyrrolo[1,2-a]quinoxaline derivative was achieved by FT-IR, 1H-NMR, 13C-NMR, X-Ray and HRMS spectral analysis. This title compound shows interesting cytotoxic potential against several human leukemia cell lines (K562, HL60, and U937 cells).

Keywords